Clinical trial Recruiting at 1 site Interventional Ages 40 and up

Using AI and Endocuff Vision to Improve Colonoscopy Results

Official title: Comparison of The Adenoma Detection Rate Between Artificial Intelligence-assisted Colonoscopy With or Without Endocuff Vision and Standard Colonscopy: A Randomized Controlled Study

Run by E-DA Hospital · NCT05863208 · Data updated 2026-11-12

This study is testing if using artificial intelligence with a special tool called Endocuff can help doctors find more polyps during colonoscopy in adults over 20.

Quick facts

Study typeInterventional
Ages40 Years and up
SexAll
Enrollment1000 (estimated)
SponsorE-DA Hospital
Academic / other
Locations1 site (Kaohsiung City)
StatusRecruiting
StartedMay 2, 2023
Main results expectedDecember 31, 2025
Study endsDecember 31, 2026
Registry record updatedJune 27, 2025
Trial IDNCT05863208 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults over 20 years old who are scheduled for outpatient sedative colonoscopy.

Probably not a fit

Patients with a history of inflammatory bowel disease, colorectal cancer, or other specified conditions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to evaluate the effectiveness of combining artificial intelligence (AI) with Endocuff vision in improving the adenoma detection rate (ADR) during colonoscopy. It is a prospective, single-blinded, randomized controlled trial that compares three groups: one using AI with Endocuff vision, another using AI alone, and a third using standard colonoscopy techniques. Eligible participants are adults over 20 years old undergoing outpatient sedative colonoscopy, and the study will assess various parameters including polyp detection and bowel preparation quality. The goal is to determine if the combination of these technologies can enhance the quality of colonoscopy and reduce the risk of interval colorectal cancer.

Why it matters

Potential benefit: If successful, this approach could significantly improve the detection of adenomas during colonoscopy, potentially reducing the incidence of colorectal cancer.

How similar studies have gone: While the use of AI in colonoscopy is gaining traction, the specific combination of AI and Endocuff vision is a novel approach that has not been extensively tested in prior studies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Patients over 20 years old are undergoing outpatient sedative colonoscopy in the E-Da Hospital, E-Da cancer Hospital and Chung Shan Medical University Hospital in Taiwan

Exclusion Criteria:

* A prior history of of inflammatory bowel disease, colorectal cancer, previous bowel resection, Peutz-Jeghers syndrome, familial adenomatous polyposis or other polyposis syndromes
* Bleeding tendency
* For scheduled endoscopic treatment

Where it's running

  • E-DA Hospital
    Kaohsiung City, Taiwan
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.